Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CLSK vs OPY: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OPY Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

OPY Overall Winner 6-Pillar Tally: CLSK 1 – 5 OPY Matrix Metrics: CLSK 1 – 9 OPY

As of Nov 16, 2026, Oppenheimer Holdings, Inc. (OPY) is the stronger overall head-to-head candidate over Cleanspark Inc (CLSK) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CLSK carries a Unified Composite Score of 50.7/100 (HOLD) at $6.27 (30.5x Forward P/E, -189.5% operating margin), whereas OPY carries 60.7/100 (BUY) at $87.40 (10.8x Forward P/E, 21.5% operating margin).

  • Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile OPY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CLSK vs OPY
CLSK NASDAQ
Cleanspark Inc
Finance Services
$6.27
-5.72% 1D
Market Cap $1.7B
TTM Revenue $679M
Forward P/E 30.5x
Beta / 30D Vol 3.28β · 127% Vol
Unified Composite Score
50.7 / 100 HOLD
Tech 45.0 Fund 57.0 Flow 69.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.1%), weak momentum, RSI 35
RSI-14: 35.4 · SMA20: $7.39 · SMA50: $10.36
OPY NYSE Head-to-Head Winner
Oppenheimer Holdings, Inc.
Security Brokers, Dealers & Flotation Companies
$87.40
-2.07% 1D
Market Cap $960.6M
TTM Revenue $1.67B
Forward P/E 10.8x
Beta / 30D Vol 1.33β · 81% Vol
Unified Composite Score
60.7 / 100 BUY
Tech 81.0 Fund 67.0 Flow 54.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.5%), weak momentum, RSI 35
RSI-14: 34.6 · SMA20: $95.05 · SMA50: $107.45

6-Pillar Scorecard Institutional Category Breakdown (CLSK 1 – 5 OPY)

Columns: Metric · CLSK · OPY
1. Valuation Multiples OPY
Forward P/E 30.5x 10.8x
Trailing P/E 30.5x 11.8x
PEG Ratio N/M 12.00x
EV / Revenue 4.8x 1.1x
2. Growth & Scale OPY
Revenue Growth (YoY) -30.5% -10.4%
Earnings Growth (YoY) +491.6% -75.3%
TTM Revenue (USD) $679M $1.67B
Market Cap $1.7B $960.6M
3. Profitability & Quality OPY
Gross Margin 47.0% 91.7%
Operating Margin -189.5% 21.5%
Net Profit Margin -146.9% 5.2%
Return on Equity (ROE) -68.6% 8.9%
4. Balance Sheet & Cash Flow OPY
Cash Generation (TTM) -$1.04B $57M
Cash Flow Margin N/A 3.4%
Net Cash / Leverage $1.58B Net Debt (2.35x D/E) $867M Net Debt (0.91x D/E)
Dividend Yield None (0.00%) 0.85%
5. Options & Positioning CLSK
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 100.6% (47th %ile) 35.2% (8th %ile)
Put/Call OI Skew 0.66x (Call-Skewed) 2.00x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat OPY
OpEx & R&D Intensity N/A 70.2% of Rev ($1.18B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CLSK (1) vs OPY (9)
Institutional Metric CLSK OPY Criterion Row Edge
Market Capitalization
Scale
$1.7B $960.6M Larger Scale CLSK
Trailing P/E Ratio
Valuation
30.5x 11.8x Lower Multiple OPY
Forward P/E Ratio
Valuation
30.5x 10.8x Lower Multiple OPY
Revenue Growth (YoY)
Growth
-30.5% -10.4% Higher Growth OPY
Operating Margin (TTM)
Profitability
-189.5% 21.5% Higher Margin OPY
Net Profit Margin
Profitability
-146.9% 5.2% Higher Margin OPY
Return on Equity (ROE)
Capital Efficiency
-68.6% 8.9% Higher ROE OPY
52-Week Range Position
Momentum
5% ($6–$19) 38% ($64–$126) Stronger Trend OPY
Beta / 30D Volatility
Risk Regime
3.28β · 127% Vol 1.33β · 81% Vol Lower Realized Risk OPY
Unified Institutional Score
Composite Signal
50.7 / 100 (HOLD) 60.7 / 100 (BUY) Higher Composite OPY
Trailing 12M Revenue (USD)
Operating Scale
$679M $1.67B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.0% 91.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 4.8x EV/Rev 12.00x PEG · 1.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$1.04B ($1.58B Net Debt (2.35x D/E)) $57M ($867M Net Debt (0.91x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon OPY +12.3 pp
CLSK: -25.36% · OPY: -13.06%
3M Horizon OPY +21.14 pp
CLSK: -46.55% · OPY: -25.41%
6M Horizon OPY +45.86 pp
CLSK: -53.35% · OPY: -7.49%
1Y Horizon OPY +75.48 pp
CLSK: -47.66% · OPY: +27.82%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CLSK Revenue OPY Revenue CLSK Op. Margin OPY Op. Margin Margin Leader
FY2018 $0M $890M -1222.9% 5.0% OPY
FY2019 $0M $930M -366.5% 8.0% OPY
FY2020 $10M $1.12B -151.0% 15.0% OPY
FY2021 $40M $1.32B -30.3% 17.0% OPY
FY2022 $130M $1.05B -28.8% 4.4% OPY
FY2023 $170M $1.07B -77.8% 4.4% OPY
FY2024 $380M $1.23B -39.3% 8.6% OPY
FY2025 $770M $1.42B 41.6% 14.8% CLSK

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CLSK BREAKDOWN
117d in phase · OBV NEUTRAL
Current IV 100.6%
IV Percentile 47th %ile
Put/Call OI Skew 0.66x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CLSK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
OPY CONSOLIDATION
144d in phase · OBV NEUTRAL
Current IV 35.2%
IV Percentile 8th %ile
Put/Call OI Skew 2.00x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact OPY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CLSK Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $1.7B market capitalization and -189.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
OPY Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $960.6M market capitalization and 21.5% operating margin.
OpEx & R&D Reinvestment 70.2% of Rev ($1.18B)
90D Engineering Disclosures 0 Published

Investor FAQ CLSK vs OPY Key Questions & Quantitative Answers

As of Nov 16, 2026, Oppenheimer Holdings, Inc. (OPY) is the stronger overall head-to-head candidate over Cleanspark Inc (CLSK) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CLSK carries a Unified Composite Score of 50.7/100 (HOLD) at $6.27 (30.5x Forward P/E, -189.5% operating margin), whereas OPY carries 60.7/100 (BUY) at $87.40 (10.8x Forward P/E, 21.5% operating margin). Technical & Structure Timing Caution: CLSK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.4); meanwhile OPY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

OPY leads the Growth & Scale pillar: CLSK posts -30.5% YoY revenue growth and +491.6% YoY earnings growth on $679M TTM revenue (47.0% gross margin, -189.5% operating margin), compared with OPY at -10.4% YoY revenue growth and -75.3% YoY earnings growth on $1.67B TTM revenue (91.7% gross margin, 21.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CLSK cumulative revenue shifted +7600.0% while OPY shifted +59.6%. In operating R&D and SG&A reinvestment, CLSK deploys N/A (0 90-day corporate R&D disclosures) versus 70.2% of Rev ($1.18B) (0 disclosures) for OPY.

OPY screens cheaper on headline valuation multiples. CLSK trades at 30.5x Forward P/E, 30.5x Trailing P/E, N/M PEG, and 4.8x EV/Revenue (unreported FCF margin), whereas OPY trades at 10.8x Forward P/E, 11.8x Trailing P/E, 12.00x PEG, and 1.1x EV/Revenue (3.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CLSK (-68.6% ROE) versus OPY (8.9% ROE) capital efficiency.

In options market volatility and institutional positioning, CLSK carries 100.6% implied volatility (47th %ile, Balanced (25th–60th %ile)), a 0.66x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.28β · 127% Vol realized risk). By comparison, OPY carries 35.2% implied volatility (8th %ile, Compressed (<25th %ile)), a 2.00x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (1.33β · 81% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.